Evidence map›Paper›PMID 30397201›Full record

ArticleNature communications2018

Recognition of host Clr-b by the inhibitory NKR-P1B receptor provides a basis for missing-self recognition.

Gautham R Balaji, Oscar A Aguilar, Miho Tanaka, Miguel A Shingu-Vazquez, Zhihui Fu, Benjamin S Gully, Lewis L Lanier, James R Carlyle, Jamie Rossjohn, Richard Berry

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. American journal of respiratory and critical care medicine · 2024
    Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Oligomeric Architecture of Mouse Activating Nkrp1 Receptors on Living Cells.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Gautham R BalajiInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia.ORCID http://orcid.org/0000-0002-7436-4689
Oscar A AguilarDepartment of Immunology, University of Toronto, Toronto, ON, M5S 1A8, Canada.ORCID http://orcid.org/0000-0002-7990-8745
Miho TanakaDepartment of Immunology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Miguel A Shingu-VazquezInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia.
Zhihui FuInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia.
Benjamin S GullyInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia.
Lewis L LanierDepartment of Microbiology and Immunology, University of California, San Francisco, CA, 94143, USA.ORCID http://orcid.org/0000-0003-1308-3952
James R CarlyleDepartment of Immunology, University of Toronto, Toronto, ON, M5S 1A8, Canada. james.carlyle@utoronto.ca.
Jamie RossjohnInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia. Jamie.rossjohn@monash.edu.ORCID http://orcid.org/0000-0002-2020-7522
Richard BerryInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia. Richard.berry@monash.edu.ORCID http://orcid.org/0000-0001-7043-0469
Australian Regenerative Medicine Institute · AUSunnybrook Health Science Centre · CADiscovery Institute · USUniversity of California, San Francisco · US

Funding

NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
Australian Research Council (ARC) FL160100049Department of Health | National Health and Medical Research Council (NHMRC) APP1109901Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 106491NIAID NIH HHS R01 AI068129
6 · The paper itself

Abstract

The interaction between natural killer (NK) cell inhibitory receptors and their cognate ligands constitutes a key mechanism by which healthy tissues are protected from NK cell-mediated lysis. However, self-ligand recognition remains poorly understood within the prototypical NKR-P1 receptor family. Here we report the structure of the inhibitory NKR-P1B receptor bound to its cognate host ligand, Clr-b. NKR-P1B and Clr-b interact via a head-to-head docking mode through an interface that includes a large array of polar interactions. NKR-P1B:Clr-b recognition is extremely sensitive to mutations at the heterodimeric interface, with most mutations severely impacting both Clr-b binding and NKR-P1B receptor function to implicate a low affinity interaction. Within the structure, two NKR-P1B:Clr-b complexes are cross-linked by a non-classic NKR-P1B homodimer, and the disruption of homodimer formation abrogates Clr-b recognition. These data provide an insight into a fundamental missing-self recognition system and suggest an avidity-based mechanism underpins NKR-P1B receptor function.

Indexed as

AnimalsCarrier ProteinsCrystallography, X-RayHEK293 CellsHumansLectins, C-TypeMiceMice, Inbred C57BLModels, MolecularMutagenesis, Site-DirectedMutationNK Cell Lectin-Like Receptor Subfamily BProtein ConformationProtein Conformation, alpha-HelicalProtein DomainsReceptors, ImmunologicCarrier ProteinsClec2d protein, mouseLectins, C-TypeNK Cell Lectin-Like Receptor Subfamily BReceptors, ImmunologicReceptors, Natural Killer Cell

Identifiers

PMID30397201
PMCPMC6218473
OpenAlexW2898861368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.